Beacon Capital Partners is a Boston-based private real estate investment firm founded in 1998, following the $4 billion acquisition of its predecessor, Beacon Properties, by EQ Office. The firm operates with a 75-year institutional real estate legacy and maintains a national footprint across 14 major U.S. markets. Beacon Capital Partners specializes in value-added investments in office and life science properties, managing a portfolio spanning more than 38 million square feet with $14 billion in investment assets under management. Since inception, the firm has raised over $19 billion in equity through ten investment funds, co-investments, and joint ventures. The firm's investment strategy focuses on acquiring, developing, and repositioning office buildings and life science facilities in gateway and high-growth markets. Beacon Capital Partners maintains a presence in Boston, Chicago, Denver, Houston, Los Angeles, New York, San Francisco, Seattle, Washington D.C., Austin, Boulder, Atlanta, Salt Lake City, and the Philadelphia region. The firm's portfolio includes trophy office towers in central business districts and life science campuses serving pharmaceutical, biotech, and research institutions. Geographic concentration is spread across these 14 markets, with notable holdings in Boston, Chicago, and San Francisco representing a substantial portion of the portfolio. Recent activity includes the May 2025 acquisition of a 25% stake in One Front, a San Francisco office tower, for $255 million, and the January 2022 purchase of 1800 Larimer in Denver for $291 million. In April 2024, Beacon acquired 333 West Wacker in Chicago for $125 million and completed a $32 million renovation by August 2025. The firm employs 111 professionals as of March 2025, operating under the leadership of President and CEO Fred Seigel, Chief Investment Officer Jeff Brown, and Chief Financial Officer Nate Adams. Beacon Capital Partners maintains a diversified tenant base across professional services, technology, life sciences, and financial services sectors. Major tenants include law firms, technology companies, and life science enterprises, though specific tenant concentration data is not publicly disclosed. The firm has demonstrated an active capital deployment strategy in recent years, securing $149 million in financing for a Boston life science building in October 2025 and completing multiple renovations and repositioning projects across its portfolio. Beacon Capital Partners manages real estate assets valued at $13 billion, including debt, co-investments, and joint venture interests.